Strata Critical Medical, Inc.(SRTA)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
SRTA is scheduled to report on Nov 9, 2026, usually before the market opens. Analysts expect EPS of $0.01.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±11.5%).
Did the stock rise after good news?
The next-day move after each of its last 7 EPS beats and 2 misses.
In plain words: it beat expectations 7 times, but the stock still fell 3 of those 7 times.
- May '26Beat▲ +10.6%
- Mar '26Missed▲ +6.9%
- Nov '25Missed▲ +9.5%
- Aug '25Beat▼ -6.1%
- May '25Beat▲ +18.5%
- Mar '25Beat▲ +7.1%
- Nov '24Beat▼ -8.9%
- May '24Beat▼ -1.1%
- Nov '23Beat▲ +29.5%
Clear beats and misses with a known reaction only. What counts as a beat
Why did SRTA fall after beating earnings?
5 of SRTA's last 9 reactions went against the EPS result. What stands out in each:
SRTA beat EPS estimates in 7 quarters, and the stock still closed lower the next day 3 times. In 3 of the 3 where we have price data, the stock had already run up before the report.
- Aug 5, 2025EPS beat +20.0%stock -6.1% next day
- It had risen 5.7% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 6.8% lower as soon as trading resumed.
- Nov 12, 2024EPS beat +50.0%stock -8.9% next day
- It had risen 10.4% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 3.7% lower as soon as trading resumed.
- May 7, 2024EPS beat +9.1%stock -1.1% next day
- It had risen 8.7% in the final week before the report, so good news may already have been priced in.
Rose despite an EPS miss (2 of 2)
- Mar 3, 2026EPS missed -500.0%stock +6.9% next day
- It had already fallen 8.0% in the 20 trading sessions before the report, so weak results may have been expected.
- Nov 10, 2025EPS missed -500.0%stock +9.5% next day
- It had already fallen 5.9% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 7.7% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was SRTA's earnings move already priced in?
SRTA's move in the month before each of its last 10 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 10 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does SRTA hold its opening gap after earnings?
SRTA's opening move after each report and where it closed that day.
In 7 reports SRTA opened at least 1% away from the previous close. It gave back half or more of that gap by the close 0 of 7 times (0%). Gaps up faded 0 of 5; gaps down recovered 0 of 2.
- May 6, 2026HeldOpened +13.9%, closed +10.6%
- Nov 10, 2025HeldOpened +7.7%, closed +9.5%
- Aug 5, 2025HeldOpened -6.8%, closed -6.1%
- May 12, 2025HeldOpened +13.0%, closed +18.5%
- Nov 12, 2024HeldOpened -3.7%, closed -8.9%
- Aug 7, 2024HeldOpened +6.1%, closed +17.3%
- Nov 8, 2023HeldOpened +22.0%, closed +29.5%
What the history says
- It fell after 3 of its 7 EPS beats (43%): beating estimates has not been enough on its own.
SRTA earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Before open | -$0.02 | -$0.12 | -500.0% | — | — |
| May 6, 2026 | Before open | -$0.04 | $0.04 | +200.0% | +10.58% | +15.56% |
| Mar 3, 2026 | Market hours | -$0.01 | -$0.06 | -500.0% | +6.90% | +5.79% |
| Nov 10, 2025 | Before open | -$0.02 | -$0.12 | -500.0% | +9.48% | +15.12% |
| Aug 5, 2025 | Before open | -$0.05 | -$0.04 | +20.0% | -6.09% | -14.90% |
| May 12, 2025 | Before open | -$0.10 | -$0.07 | +30.0% | +18.49% | +18.49% |
| Mar 13, 2025 | Market hours | -$0.10 | -$0.05 | +50.0% | +7.07% | +12.37% |
| Nov 12, 2024 | Before open | -$0.02 | -$0.01 | +50.0% | -8.88% | -10.71% |
| Aug 7, 2024 | After close | -$0.06 | -$0.06 | 0.0% | +17.33% | +3.61% |
| May 7, 2024 | Market hours | -$0.11 | -$0.10 | +9.1% | -1.11% | -0.83% |
| Mar 12, 2024 | After close | -$0.09 | -$0.10 | -11.1% | — | — |
| Nov 8, 2023 | Before open | -$0.06 | -$0.02 | +66.7% | +29.52% | +40.53% |
Consensus for the next report: EPS $0.01, revenue $74.12M.
SRTA Earnings FAQ
Answers computed from Strata Critical Medical, Inc.'s reported history
SRTA is scheduled to report on Nov 9, 2026, usually before the market opens. Analysts expect EPS of $0.01.
Over the last 12 quarters with a usable EPS surprise, SRTA beat the consensus estimate 7 times (58%), missed 4 and landed in line 1.
Across its last 10 quarters with a measured reaction, SRTA moved an average of ±11.5% in the first session after reporting. It closed higher 70% of the time; the largest gain was 29.5% and the largest drop -8.9%.
SRTA fell in the first session after 3 of its last 7 EPS beats (43%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 3 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 10 quarters with price data, SRTA moved an average of -1.9% in the 20 trading sessions before reporting and was higher in 40% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging +3.5%. After a drop of 3% or more (6 quarters), it rose the next day 83% of the time, averaging +11.5%. This describes past reports; it is not a forecast.
In 7 reports SRTA opened at least 1% away from the previous close. It gave back half or more of that gap by the close 0 of 7 times (0%), and fully reversed 0 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · SRTA: 12 reported quarters, latest Aug 4, 2026. Information only, not investment advice.
Looking for more on SRTA?
Price charts, forecast, fundamentals and risk pages for SRTA are not on Tickzen yet. You can run a full stock analysis now.
Run the SRTA Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun